Citigroup Inc Biomea Fusion, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Citigroup Inc holds 20,606 shares of BMEA stock, worth $134,557. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,606

Previous 21,424 3.82%

Holding current value

$134,557

Previous $96,000 116.67%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$4.23 - $10.1 $3,460 - $8,261	-818 Reduced 3.82%	20,606 $208,000
Q2 2024 Aug 12, 2024	SELL	$4.14 - $15.3 $1.61 Million - $5.94 Million	-388,134 Reduced 94.77%	21,424 $96,000
Q1 2024 May 10, 2024	BUY	$13.92 - $19.5 $4.96 Million - $6.95 Million	356,365 Added 669.95%	409,558 $6.12 Million
Q4 2023 Feb 09, 2024	SELL	$8.37 - $19.8 $526,816 - $1.25 Million	-62,941 Reduced 54.2%	53,193 $772,000
Q3 2023 Nov 09, 2023	BUY	$13.44 - $23.02 $830,726 - $1.42 Million	61,810 Added 113.78%	116,134 $1.6 Million
Q2 2023 Aug 10, 2023	BUY	$21.66 - $41.8 $180,925 - $349,155	8,353 Added 18.17%	54,324 $1.19 Million
Q1 2023 May 11, 2023	BUY	$6.8 - $32.35 $56,317 - $267,922	8,282 Added 21.97%	45,971 $1.43 Million
Q4 2022 Feb 09, 2023	BUY	$6.3 - $11.6 $223,139 - $410,860	35,419 Added 1560.31%	37,689 $317,000
Q3 2022 Nov 10, 2022	BUY	$9.51 - $13.61 $3,604 - $5,158	379 Added 20.04%	2,270 $22,000
Q2 2022 Aug 10, 2022	SELL	$3.0 - $12.03 $996 - $3,993	-332 Reduced 14.93%	1,891 $23,000
Q1 2022 May 12, 2022	SELL	$4.39 - $9.03 $23,517 - $48,373	-5,357 Reduced 70.67%	2,223 $10,000
Q4 2021 Feb 10, 2022	BUY	$7.22 - $12.72 $44,699 - $78,749	6,191 Added 445.72%	7,580 $56,000
Q3 2021 Nov 10, 2021	BUY	$10.0 - $15.99 $13,890 - $22,210	1,389 New	1,389 $17,000

Others Institutions Holding BMEA

# of Institutions

105

Shares Held

17.9M

Call Options Held

1.68M

Put Options Held

410K

View Full List

About Biomea Fusion, Inc.

Ticker BMEA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,290,600
Market Cap $191M
Description
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...

More about BMEA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account